Lyra Medical ^Companies

Lyra Medical has developed a new implant for the surgical treatment of pelvic organ prolapse (POP). The proprietary, patented self-retaining support (SRS) technology eliminates the need for complex anchoring techniques that compromise the safety and long-term success of existing treatments solutions.
Lyra's technology mimics the natural anatomy and restores pelvic organs to their functional and physiological location. It represents a new anchorless method that significantly improves current transvaginal mesh (TVM) solutions. SRS technology was developed to eliminate the high complication rate associated with current anchored TVMs and reverse the low success rate associated with native-tissue repair.